Applications are open to the ANDHealth+ 2018 Program.
ANDHealth+ provides critical financial and strategic input into mid-stage digital health companies looking to raise growth capital or enter international healthcare markets. Successful applicants will receive up to $60,000 funding to access specialist third party services and activities, and up to $150,000 of in kind support to enhance their ability to penetrate global markets and/ or raise significant growth capital. No transfer of equity or intellectual property rights is required to be a participant in the ANDHealth program. Apply until May 31, more information via our website.
“I highly recommend any ambitious digital health companies looking to turbo-charge their clinical or commercial validation, to apply to the ANDHealth+ program”